CECOG has created a platform with the aim to reduce health inequalities and to improve patient access to cancer care. The subject of discussion is the value of new treatments to create willingness to invest in improving cancer outcomes while managing the budget. The platform includes various stakeholders as scientific leaders, policy makers, payers, patients and industry.
The origins of the GOIA initiative. Why was it created!
Cancer mortality varies widely across Europe, and survival depends on where you live. In particular, the inequality between countries in Central and South-Eastern Europe (CEE) and Western Europe (WE) is striking. The COVID-19 pandemic has brought existing inequalities into sharp focus, and the economic disruption it has caused threatens to deepen them.
How can we prevent this, and what is more, how can we drive lasting change towards equitable cancer care? Working within the frame of Europe’s “Beating Cancer” plan, the Central European Cooperative Oncology Group (CECOG) is running the “CEE Access to Cancer Care Program”.
Here, multisectoral experts have developed a Comprehensive Dashboard for CEE, comprising the whole pathway from prevention to survival by focusing on improved patients’ outcomes.
| First Name | Last Name | Country | 19.11.2018 Vienna | 29.03.2019 Bucharest | 22.09.2019 Zagreb | 27.10.2019 Warsaw | 31.01.2020 Vienna | |
|---|---|---|---|---|---|---|---|---|
| Christoph | Zielinski | CECOG | AT | x | x | x | x | x |
| Christiane | Thallinger | CECOG | AT | x | x | x | x | x |
| Patriciu | Achimas Cadariu | Medical Director, Oncologic Institute Ion Chiricuta, Cluj, Romania | RO | x | x | |||
| Tit | Albreht | Centre for Health Care National Institute of Public Health, EUPHA | SLO | x | x | |||
| Ivica | Belina | Kuz - Coalition Of Association In Healthcare | HR | x | ||||
| Florin | Buicu | Vicepresident Committee for Health and Family | RO | x | ||||
| Cristian Silviu | Busoi | Member European Parliament | RO | x | x | |||
| Krunoslav | Capak | Croatian National Institute of Public Health | HR | X | ||||
| Antonella | Cardone | ECPC | UK | x | x | |||
| Larisa | Catrinici | Oncology Institute of Chisinau | MDA | x | ||||
| Tudor | Ciuleanu | Professor of Oncology, Cluj Napoca | RO | x | x | |||
| Alina | Comanescu | Founder, Asociația Sănătate pentru Comunitate | RO | x | x | x | x | x |
| Adriana | Cotel | Healthcare Provider Strategies & Solutions S.R.L. | RO | x | ||||
| Tanja | Cufer | Professor of Oncology, University Clinic Golnik, Medical Faculty Ljubljana | SLO | x | x | x | x | |
| Piotr | Czauderna | consultant at Medical University of Gdansk, Tri-City Central Animal Laboratory – Research and Service Centre | PL | x | ||||
| Dana | Deac | Journalist. | RO | x | x | |||
| Ana | Dodea | Director, Policy & Market Access MSD | RO | x | ||||
| Gertraud | Eckart | MSD | AT | x | x | x | x | x |
| Roxana | Ene | ASTRA ZENECA Market Access Director | RO | x | ||||
| Alexander | Eniu | Senior Medical Oncologist Hopital Riviera-Chablais, CHE | RO | x | ||||
| Rie | Fujisawa | OECD | x | |||||
| Radu | Ganescu | COPAC - Coalition of Patients' Organisations with Chronic Diseases | RO | x | ||||
| Mircea | Geoana | ASPEN Romania | RO | x | x | |||
| Stefan | Gijssels | Chair Patient Expert Center | BE | x | x | |||
| Suzanne | Hakansson | ASTRA ZENECA Vice President Healthcare Affairs | SE | x | x | |||
| Vera Katalinić | Janković | Croatian Ministry of Health, Deputy Minister, responsible for National Cancer Plan | HR | x | ||||
| Jacek | Jassem | Professor of Clinical Oncology and Radiotherapy Medical University of Gdansk | PL | x | x | x | x | |
| Zsuzsana | Kahan | Prof of Oncology - Univ Szeged | HU | x | x | |||
| Rabia | Khan | OECD Representative | UK | x | x | x | ||
| Barbara | Kiesewetter | Medical University of Vienna University Hospital for Internal Medicine I | AT | x | ||||
| Jasper | Kunow | Managing Director Central Eastern Europe at MSD | CH | x | ||||
| Attila | Laszlo | Chairman of Health Committee Senat of Rep. Romania | RO | x | ||||
| Satu | Lipponen | Dir. Strategy & foresight Cancer Society of Finland | SF | x | ||||
| Paul | Naish | AstraZeneca | UK | x | x | x | ||
| Vlad | Nicolae | Acting Executive Director at Aspen Institute Romania | RO | x | ||||
| Marta | Niculaie | ROCHE Communications Director | RO | x | ||||
| Anja | Nitzsche-Bell | IAEA (Wien) | AT | x | x | x | ||
| Carmen | Orban | Prof. Dr. Anesthesiology and Intensive care Fundeni Clin Institute | RO | x | x | x | ||
| René | Ott | Medical Director Oncology Europe, Astra Zeneca | AT | x | x | |||
| Piotr | Perkowski | Market Access Manager AZ | PL | x | ||||
| Alojz | Peterle | former MEP | SLO | x | ||||
| Ivana | Plechata | Voice of Patients | CZ | x | ||||
| Michael | Pohl | Market Access, Astra Zeneca | AT | x | ||||
| Bartosz | Polinski | Patient Advocacy Fundacja Onkologgiczna Alivia | PL | x | x | x | x | |
| Alexandru | Rafila | ASPEN Romania | RO | x | x | x | ||
| Radu | Rasinar | ASTRA ZENECA Area Vice President CEE | RO | x | x | x | ||
| Alexander | Rödiger | MSD/European Federation of Pharmaceutical Industries and Associations | CH | x | x | x | x | |
| Piotr | Rutkowski | Maria Sklodowska-Curie Institute - Oncology Center | PL | x | ||||
| Rafal | Swierzewski | President of Board Fundation for Patients with Rare Diseases COCARDA | PL | x | x | x | x | |
| Tomislav | Sokol | Member European Parliament | HR | x | ||||
| Kristine | Sorensen | Director, Global Health Literacy Academy | DNK | x | ||||
| Sandra | Steyskal | IAEA Section Head, Technical Cooperation Europe | AT | x | ||||
| Dubravka | Suica | Member European Parliament | HR | x | ||||
| Gabriela | Teodorescu | Medical and Regulatory Director, AstraZeneca Romania and Central Eastern Europe | RO | x | x | x | ||
| Damir | Vrbanec | Prof of Oncology - Univ. Pula | HR | x | x | |||
| Razvan | Vulcancescu | President, National Insurance House, Romania | RO | x | x | |||
| Nils | Wilking | Associate Professor, Karolinska Institutet, Stockholm | SE | x | x | x | x | |
| Wendy | Yared | Director, Association of European Cancer Leagues (ECL) | UK | x | x |